AXPH: Strong Fundamentals, Stretched Technical
📊 AXPH: Strong Fundamentals, Stretched Technical ⚠️
🏛️ Fundamental Review:
📊 Business Quality.
AXPH is a highly profitable pharmaceutical manufacturer with exceptional profitability and a defensive business model. 🏥
✅ Strengths & Catalysts.
A 49.3% ROE, almost debt free balance sheet, and an attractive 5.7% dividend yield make it a premium defensive stock. 🚀
⚠️ Risks.
Very limited share float and slowing quarterly momentum increase volatility and liquidity risk. ⚠️
💰 Valuation.
AXPH is an elite long term value stock, but current prices trade well above my calculated fair value. 💎
🔍 The Pulse:
AXPH confirmed a momentum breakout from a flag pattern. 📈
The rally has pushed the stock into an overbought and stretched technical position. ⚠️
My calculated fair value stands near 980 EGP, well below the current price. 💎
For aggressive investors, I prefer accumulating on a pullback around 1,187 EGP. 🎯
If price fails to break 1,378 EGP next week, a deeper pullback toward 1,156 EGP becomes increasingly likely. 🔄
🧱 The Key Structural Boundaries
🛡️ First Support, 1,156 EGP.
The previous major resistance that should act as support on any correction.
🛡️ Recommended Entry, 1,187 EGP.
My preferred accumulation level for investors willing to accept the risk.
🚀 Breakout Trigger, 1,378 EGP.
A close above this level confirms the next bullish expansion.
💎 Fair Value, 980 EGP.
My calculated fair value for the stock.
🎯 The Verdict:
AXPH remains one of the strongest defensive businesses on the EGX.
The technical picture is bullish, but the stock is significantly stretched.
Avoid chasing the current rally and wait for a healthier entry.
A failure to break 1,378 EGP could trigger a pullback toward 1,156 EGP.
---
If you like my insights, follow and boost! 🙌💙🚀
🎁 $15 TradingView Discount:
🔗 tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑
🏛️ Fundamental Review:
📊 Business Quality.
AXPH is a highly profitable pharmaceutical manufacturer with exceptional profitability and a defensive business model. 🏥
✅ Strengths & Catalysts.
A 49.3% ROE, almost debt free balance sheet, and an attractive 5.7% dividend yield make it a premium defensive stock. 🚀
⚠️ Risks.
Very limited share float and slowing quarterly momentum increase volatility and liquidity risk. ⚠️
💰 Valuation.
AXPH is an elite long term value stock, but current prices trade well above my calculated fair value. 💎
🔍 The Pulse:
AXPH confirmed a momentum breakout from a flag pattern. 📈
The rally has pushed the stock into an overbought and stretched technical position. ⚠️
My calculated fair value stands near 980 EGP, well below the current price. 💎
For aggressive investors, I prefer accumulating on a pullback around 1,187 EGP. 🎯
If price fails to break 1,378 EGP next week, a deeper pullback toward 1,156 EGP becomes increasingly likely. 🔄
🧱 The Key Structural Boundaries
🛡️ First Support, 1,156 EGP.
The previous major resistance that should act as support on any correction.
🛡️ Recommended Entry, 1,187 EGP.
My preferred accumulation level for investors willing to accept the risk.
🚀 Breakout Trigger, 1,378 EGP.
A close above this level confirms the next bullish expansion.
💎 Fair Value, 980 EGP.
My calculated fair value for the stock.
🎯 The Verdict:
AXPH remains one of the strongest defensive businesses on the EGX.
The technical picture is bullish, but the stock is significantly stretched.
Avoid chasing the current rally and wait for a healthier entry.
A failure to break 1,378 EGP could trigger a pullback toward 1,156 EGP.
---
If you like my insights, follow and boost! 🙌💙🚀
🎁 $15 TradingView Discount:
🔗 tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.